We are always available to take your enquiries. Please send an email or give us a call. For general press inquiries, please call +45 3643 3000.

Please note that the contacts listed to the right are for journalists or people with media related questions. If you are not a journalist, please visit the contact page and consult the appropriate Lundbeck contact.

About Lundbeck
We are a global pharmaceutical company engaged in the research and development, production, marketing, sale and distribution of drugs for the treatment of brain disorders such as depression, schizophrenia, Alzheimer’s disease, Parkinson’s disease, Huntington's disease, epilepsy and insomnia.

Lundbeck is among the companies which have the largest research spend as a percentage of revenue. In total we employ more than 1,400 highly qualified and specialised employees in our research and development departments.

Every year Lundbeck invests around 20 percent of its revenue in the research and development of new innovative drugs, which will improve the treatment of the millions of people suffering from brain disorders all over the world.

In total Lundbeck, headquartered in Copenhagen, Denmark, employs more than 5.900 people all over the world, 2.000 of which work in Denmark. Lundbeck has employees in 57 countries.

The figures above are from the end of 2010.